A Straumann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Straumann

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

Gut|October 16, 2009

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialA Straumann, S Conus, P Grzonka, et al.

Alimentary Pharmacology & Therapeutics|August 29, 2015

Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitisC Schlag, S Miehlke, A Heiseke, et al.

Allergy|January 23, 2016

Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivityD Simon, A Cianferoni, J M Spergel, et al.

Alimentary Pharmacology & Therapeutics|August 15, 2015

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activityE Safroneeva, M Coslovsky, C E Kuehni, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

Gut|October 16, 2009

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trialA Straumann, S Conus, P Grzonka, et al.

Alimentary Pharmacology & Therapeutics|August 29, 2015

Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitisC Schlag, S Miehlke, A Heiseke, et al.

Allergy|January 23, 2016

Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivityD Simon, A Cianferoni, J M Spergel, et al.

Alimentary Pharmacology & Therapeutics|August 15, 2015

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activityE Safroneeva, M Coslovsky, C E Kuehni, et al.

Pageof 5